CURRICULUM VITAE
Richard Bihrle, M.D.
OFFICE ADDRESS:
Department of Urology
535 N. Barnhill Drive, Suite 420
Indiana University School of Medicine
Indianapolis, Indiana 46202-5289
317-278-9300
DATE AND PLACE
OF BIRTH:
December 16, 1952
Newport News, Virginia
CITIZENSHIP:
U.S. Citizen
EDUCATION:
1974
B.S., Georgetown University
Washington, D.C.
1979
M.D., Georgetown University Medical School
Washington, D.C.
POSTGRADUATE MEDICAL TRAINING:
1979-1980
Internship, General Surgery
Tufts New England Medical Center
Boston, Massachusetts
1980-1981
Assistant Resident in General Surgery
Tufts New England Medical Center
Boston, Massachusetts
1981-1982
Assistant Resident in Urology
Lahey Clinic Medical Center
Burlington, Massachusetts
1982-1983
Associate Resident in Urology
Children’s Hospital Medical Center
Boston, Massachusetts
1983-1984
Chief Resident in Urology
Lahey Clinic Medical Center
Burlington, Massachusetts
1
Richard Bihrle, M.D.
CV
ACADEMIC APPOINTMENTS:
1984-1990
Assistant Professor of Urology
Indiana University School of Medicine
Indianapolis, Indiana
1990-1996
Associate Professor of Urology
Indiana University School of Medicine
Indianapolis, Indiana
1996-present
Professor of Urology
Indiana University School of Medicine
Indianapolis, Indiana
HOSPITAL APPOINTMENTS:
Indiana University Hospital
550 N. University Boulevard
Indianapolis, Indiana
Wishard Memorial Hospital
1001 West 10th Street
Indianapolis, Indiana
Richard Roudebush Veterans Medical Center
1481 West 10th Street
Indianapolis, Indiana
BOARD CERTIFICATION:
American Board of Urology, 1986
Recertification American Board of Urology, 1996
Recertification American Board of Urology, 2006
PROFESSIONAL SOCIETIES:
North Central Section of American Urologic Association
American Urologic Association
Society of University Urologists
John Shaw Billings Medical Historical Society
Society of International Urology
Genitourinary Reconstructive Surgeons
EDITORIAL:
Reviewer:
2/16/16
Journal of Urology, 1989-Present
Journal of Vascular and Interventional Radiology,
1990-Present
Urology, 1993-present
Page 2
Richard Bihrle, M.D.
CV
Awards Committee: New York Section Valentine Essay, 1985
North Central Section of AUA, 1988
HONORS AND AWARDS:
(Since Matriculating at Indiana University in 1984)
1989:
Outstanding Clinical Instructor from the Class of 1989
1990:
Outstanding Clinical Instructor from the Class of 1990
1991:
First Prize-Countway Harvard Research Award for
delineation of the role of plication of the ileocecal valve
and collagen augmentation of the ileocecal valve to
enhance continence.
2006:
Outstanding Clinical Instructor from the Class of 2006
2007:
Dr. Norbert M. Welch, Sr. and Louise A. Welch Professor
of Urology Chair
UNIVERSITY SERVICE:
Laser Committee 1987 - present
Quality Assurance Committee 1986 - present
Urology Chairman Search and Screen Committee 1994
COMMUNITY SERVICE:
Member of Park Tudor Fathers' Association
Vice-President of Meetinghouse Road AssociationMartha’s Vineyards, MA.
2/16/16
Page 3
Richard Bihrle, M.D.
CV
PUBLICATIONS:
1.
Rowland, R.G., Mitchell, M.E. and Bihrle, R.: The cecoileal continent urinary
reservoir. World J. Urol. 3:185-190. 1985.
2.
Piser, J.A., Rowland, R.G., Mitchell, M.E., Bihrle, R. and Kahnoski, R.J.: New
cecoileal continent urinary reservoir variation successful. Urology Times. 1987.
Jan;14:No.1.
3.
Bihrle, R., Donohue, J.P. and Rowland, R.G.: Nonseminomatous testes Cancer. In:
Rous, S.: Urology Annual. Vol. I:87-99, 1987.
4.
Rowland, R.G., Mitchell, M.E., Bihrle, R., Kahnoski, R.J. and Piser, J.A. Indiana
continent urinary reservoir. J. Urol. 1987 Jun;137:1136-1139.
5.
Rowland, R.G., Mitchell, M.E., Bihrle, R. Alternative techniques for a continent
urinary reservoir. Urol Clin North Am. 1987 Nov;14(4):797-804.
6.
Brito, C.G., Bloch, T., Foster, R.S., and Bihrle, R.: Testicular papillary
cystadenomatous tumor of low malignant potential: Case report and discussion of
literature. J Urol. 139:378, 1988.
7.
Foster, R.S., Mahomed, Y., Bihrle, R. and Strup, S.: Use of a caval-atrial shunt for
resection of a caval tumor thrombus in renal cell carcinoma. J Urol. 140:1317, 1988.
8.
Bihrle, R., Donohue, J.P., Foster, R.S. Complications of retroperitoneal lymph node
dissection. Urol Clin North Am. 1988 May;15(2):237-42.
9.
Bihrle, R., Foster, R.S., Steidle, C.P., Adams, M.C., Woodbury, P.W. and McNulty,
A.: Creation of a transverse colon-gastric composite reservoir: A new technique. J
Urol. 141:1217-1220, 1989.
10.
Hockley, N.M., Bihrle, R., Bennett, R.M., III, and Curry, J.M.: Congenital
genitourinary hemangiomas in a patient with Klippel-Trenaunay syndrome:
Management with the neodymium:YAG laser. J Urol. 141:940-941, 1989.
11.
Bihrle, R., Brito, C.G., Adams, M.C., Woodbury, P.W. and Foster, R.S.:
Construction of an antirefluxing urinary conduit using a plicated ileocecal segment. J
Urol. 142:1567- 1569, 1989.
12.
Kopecky, K.K., Sutton, G.P., Bihrle, R. and Becker, G.J.: Percutaneous transrenal
endoureteral radio-frequency electrocautery for occlusion: Case Report. Radiology.
170:1047-1048, March 1989.
13.
Kopecky, K.K., Steidle, C.P., Eble, J.N., Bihrle, R., Dreesen, R.G., McNulty, A.M.,
Sutton, G.P. and Becker, G.J.: Endoluminal radio-frequency electrocautery for
permanent ureteral occlusion in swine. Radiology. 170:1043-1046, March 1989.
2/16/16
Page 4
Richard Bihrle, M.D.
CV
14.
Foster, R.S., Donohue, J.P., Bihrle, R. and Rowland, R.G.: Surgical therapy of
postchemotherapy testicular cancer. Advances in Oncology. Vol. 5, No. 3:22-24,
1989.
15.
Scheidler, D.M., Foster, R.S., Bihrle, R., Scott, J.W. and Litwiller, S.E.: Anastomotic
suture granuloma following radical retropubic prostatectomy. J. Urol. 143:133-134,
1990.
16.
Hockley, N.M., Foster, R.S., Bihrle, R., Steidle, C.P. and Kopecky, K.K.: The use of
magnetic resonance imaging to determine the surgical approach to renal cell
carcinoma with vena caval extension. Urology. Vol. XXXVI, No. 1:55-60, 1990.
17.
Donohue, J.P., Thornhill, J.T., Foster, R.S., Rowland, R.G. and Bihrle, R.
Indications for resection of great vessels during extended RPLND. J Urol. 143:396A,
No. 831, 1990.
18.
Bihrle, R. and Rowland, R.G.: Continent urinary diversion: Indiana pouch. Profiles
in Urology. 1-15, 1990.
19.
Rowland, R.G. and Bihrle, R.: Continent urinary diversion. Landmarks in Urology.
1990.
20.
Donohue, J.P., Foster, R.S., Rowland, R.G., Bihrle, R., Jones, J., Geier, G. Nervesparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol.
1990 Aug;144(2Pt 1):287-91.
21.
Rink, R.C. and Bihrle, R.: Continent urinary diversion in children and the Indiana
pouch. Problems in Urology. 1990. Dec;4:663.
22.
Rowland, R.G., Bihrle, R. Scheidler, D., Foster, R.S. and Klee, L.W.: Update on the
Indiana continent reservoir. Problems in Urology. 1991. Jun;5:269.
23.
Bihrle, R., Klee, L.W., and Foster, R.S.: Transverse colon-gastric tube composite
reservoir. Problems in Urology. 1991. Jun;5:292.
24.
Bihrle, R. and Klee, L.W.: The transverse colon-gastric composite reservoir.
Aktuelle Urologica. Jan. 1991.
25.
Donohue, J.P., Foster, R.S., Rowland, R.G., Bihrle, R., Jones, J.A. and Geier, G.E.:
Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J.
Urol. 144:287, 1990.
26.
Bihrle, R., Klee, L.W., Adams, M.C., Steidle, C.P. and Foster, R.S.: Transverse
colon-gastric tube composite reservoir. Urology. 37:36, 1991.
2/16/16
Page 5
Richard Bihrle, M.D.
CV
27.
Foster, R.S., Donohue, J.P. and Bihrle, R.: Stage A nonseminomatous testis
carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy.
Urologica Internationalis. 46:294-297, 1991.
28.
Foster, R.S., Rubin, L.R., McNulty, A., Bihrle, R. and Donohue, J.P.: The detection
of serum antisperm antibodies in patients with primary testicular cancer. International
Journal of Andrology. 14:179-185, 1991.
29.
Bihrle, R., Klee, L.W., Adams, M.C. and Foster, R.S.: Early clinical experience with
the transverse colon-gastric tube continent urinary reservoir. J Urol. 146:751-753.
1991.
30.
Klee, L.W., Brito, C.G., Bihrle, R., Dreesen, R.G., Canal, D.F. and Foster, R.S.:
Laparoscopic spermatic vein ligation in canines. J. EndoUrology. Vol. 5, No. 4,
1991.
31.
Sanghvi, N.T., Foster, R.S., Fry, F.J., Bihrle, R., Snoddy, A.M., Griffith, S.L. and
Franklin, T.D.: Preliminary findings of treatment of canine prostatic tissue using high
intensity focused ultrasound. J. Ultrasound in Medicine. 1991. Mar;10:Sl, pp 45.
32.
Sanghvi, N.T., Foster, R.S., Fry, F.J., Bihrle, B., Snoddy, A.M., Griffith, S.L.,
Franklin, T.D. and Zink, J.: Noninvasive transrectal ultrasound device for prostatic
tissue visualization and tissue ablation in the focal zone using high intensity focused
beam. J. Ultrasound in Medicine. 1991. Mar;10:Sl, pp 46.
33.
Donohue, J.P., Thornhill, J.A., Foster, R.S., Rowland, R.G. and Bihrle, R.: Resection
of the inferior vena cava or intraluminal vena caval tumor thrombectomy during
retroperitoneal lymph node dissection for metastatic germ cell cancer: indications and
results. J Urol. 1991. Aug;Vol. 146:346-349.
34.
Klee, L.W., Rink, R.C., Bihrle, R. and Foster, R.S.: Laparoscopic varicocele
ligation. Dialogues in Pediatric Urology. 1992. Feb;Vol. 15,No. 2.
35.
Adams, M.C., Bihrle, R., Foster, R.S. and Brito, C.G.: Conversion of an ileal conduit
to a continent catheterizable stoma. J Urol. 1992. Jan;Vol. 147:126-128.
36.
Kopecky, K.K., Brendle, M.T., Harman, J.T., Foster, R.S., Bihrle, R. and Loehrer,
P.J.: Testicular ultrasonography after chemotherapy for germ cell neoplasm:
significance of highly hypoechoic lesions. Urology. 1992. May;39:490-494.
37.
Donohue, J.P., Bihrle, R., Hautmann, R.E., and Skinner, D.G.: A view of continent
urinary diversion today. Contemporary Urology. 4(12):31-43, 1992.
38.
Haney, P.T., Bihrle, R. and Kopecky, K.K.: Percutaneous management of a
nephrocutaneous fistula due to a pyelocaliceal diverticular calculus. J Urol. on
Calculi. 1992. Sep;148:1105-110.
2/16/16
Page 6
Richard Bihrle, M.D.
CV
39.
Jones, J.A., Foster, R.S. and Bihrle, R.: Hepatic mobilization: useful, expeditious
maneuver. Contemporary Urol. 1992. Aug;Vol. 4, No. 8:49-68.
40.
Bihrle, R., Skinner, D., Hautmann, R., and Donohue, J.P.: Symposium: continent
urinary diversion part I. Contemporary Urol. 1992. Dec;Vol. 4, No. 12:31-43.
41.
Sanghvi, N.T., Foster, R.S., Fry, F.J., Bihrle, R., Hennige, C. and Hennige, L.V.:
Ultrasound intracavity system for imaging therapy planning and treatment of focal
disease. Ultrasonic, Ferroelectrics and Frequency Control Symposium. 1992.
42.
Bihrle, R., Skinner, D., Hautmann, R. and Donohue, J.P.: Symposium: Continent
urinary diversion Part II. Contemporary Urol. 1993. Jan;Vol.5, No.1:41-49.
43.
Donohue, J.P., Thornhill, J.A., Foster, R.S., Rowland, R.G. and Bihrle, R.:
Retroperitoneal anterior lymphadenectomy for clinical stage A testis cancer (1965 to
1989): modifications of technique and impact on ejaculation. J Urol. 1993.
Feb;149:237-243.
44.
Donohue, J.P., Thornhill, J.A., Foster, R.G., Rowland, R.G., and Bihrle, R.: Primary
retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell
testis Cancer (review of the Indiana University experience 1965-1989). British
Journal of Urol. 71:326-335. 1993.
45.
Bihrle, R., Foster, R.S., Sanghvi, N.T., Fry, F.J. and Regan, J.: Special report: highintensity focused ultrasound in the treatment of BPH. Prospectives. Vol.2, No.5:6-8.
1993.
46.
Foster, R.S., Bihrle, R., Sanghvi, N.T., et al: Production of prostatic lesions in canine
using transrectally administered high intensity focused ultrasound. European Urol.
23:330-336, 1993.
47.
Foster, R.S., Bihrle, R., Sanghvi, N.T., Fry, F.J. and Donohue, J.P.: High-intensity
focused ultrasound in the treatment of prostatic disease. European Urol. 23(suppl
1):29-33, 1993.
48.
Gleason, P.E., Weinberger, M.H., Pratt, J.H., Bihrle, R., Dugan, J., Eller, D. and
Donohue, J.P.: Evaluation of diagnostic tests in the differential diagnosis of primary
aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia. J Urol.
1993. Nov;Vol. 150:1365-1368.
49.
Baniel, J., Foster, R.S., Rowland, R.G., Bihrle, R. and Donohue, J.P.: Management of
chylous ascites after retroperitoneal lymph node dissection for testicular cancer. J.
Urol. Vol. 150: 1422-1424, Nov. 1993.
50.
Foster, R.S., Bennett, R.M., Bihrle, R. and Donohue, J.P.: Preliminary report:
postoperative fertility assessment in nerve-sparing RPLND patients. European Urol.
Vol. 23, No.1:165-168, 1993.
2/16/16
Page 7
Richard Bihrle, M.D.
CV
51.
Sanghvi, N.T., Foster, R.S., Fry, F.J., Bihrle, R., Hennige, C. and Hennige, L.V.:
Ultrasound intracavity system for imaging, therapy planning and treatment of focal
disease. Ultrasonics Symposium Proceedings. 1249-1253, 1993.
52.
Sanghvi, N.T., Foster, R.S., Bihrle, R., Fry, F.J., Phillips, M. and Hennige, C.:
Transrectal ablation of prostate tissue using focused ultrasound. IEEE Ultrasonic
Symposium. 1993.
53.
Foster, R.S. McNulty, A., Rubin, L.R., Bennett, R., Rowland, R.G., Sledge, G.W.,
Bihrle, R., Donohue, J.P. Fertility considerations in nerve-sparing retroperitoneal
lymph-node dissection. World J Urol. 1994;12(3):136-8.
54.
Donohue, J.P., Thornhill, J.A., Foster, R.S., Bihrle, R. Vascular considerations in
postchemotherapy. Retroperitoneal lymph-node dissection: Part II. World J Urol.
1994;12(4):187-9.
55.
Donohue, J.P., Thornhill, J.A., Foster, R.S., Bihrle, R. Vascular considerations in
postchemotherapy. Retroperitoneal lymph-node dissection: Part I-Vena cava. World
J Urol. 1994;12(4):182-6.
56.
Donohue, J.P., Thornhill, J.A., Foster, R.S., Rowland, R.G., Bihrle, R. Stage I
nonseminomatous germ-cell testicular cancer-management options and risk-benefit
considerations. World J Urol. 1994;12(4):170-6.
57.
Bihrle, R., Foster, R.S., Sanghvi, N.T., Fry, F.J. and Donohue, J.P.: High intensity
focused ultrasound in the treatment of prostatic tissue. Urology. Supplement to
Urology. 1994. Feb;Vol. 43, No. 2.
58.
Baniel, J., Bihrle, R., Wahle, G.R. and Foster, R.S.: Splenic rupture during occlusion
of the porta hepatis in resection of tumors with vena caval extension. J. Urol. 1994.
Apr;Vol. 151:992-994.
59.
Bihrle, R., Foster, R.S., Sanghvi, N.T., Donohue, J.P. and Hood, P.J.: High intensity
focused ultrasound for the treatment of BPH: early U.S. clinical experience. J Urol.
1994. May;Vol. 151:1271-1275.
60.
Hood, P.J., Bihrle, R., Foster, R.S. and Sanghvi, N.T.: Transrectal high intensity
focused ultrasound for treatment of BPH. J Urol. Nursing. 1994. Jun;Vol. 13, No. 2.
61.
Donohue, J.P., Thornhill, J.A., Foster, R.S., Rowland, R.G. and Bihrle, R.: Stage I
nonseminomatous germ-cell testicular cancer-management options and risk-benefit
considerations. World J.Urol. 1994. 612:1-7.
62.
Baniel, J., Foster, R.S., Rowland, R.G., Bihrle, R. and Donohue, J.P.: Complications
of primary retroperitoneal lymph node dissection. J Urol. 1994. Aug:152(2 Pt
1):424-7.
2/16/16
Page 8
Richard Bihrle, M.D.
CV
63.
Wahle, G.R., Foster, R.S., Bihrle, R., Rowland, R.G., Bennett, R.M. and Donohue,
J.P.: Nerve-sparing retroperitoneal lymphadenectomy after primary chemotherapy
for metastatic testicular carcinoma. J Urol. 1994. Aug;152(2 Pt 1):428-430.
64.
Foster, R.S., McNulty, A., Rubin, L.R., Bennett, R.M., Rowland, R.G., Sledge, G.W.,
Bihrle, R. and Donohue, J.P. Fertility of patients with clinical stage I testis cancer
managed by nerve-sparing retroperitoneal lymph node dissection. J Urol. 1994.
Oct;152(4):1139-42.
65.
Donohue, J.P., Thornhill, J.A., Foster, R.S. and Bihrle, R.: Vascular considerations in
postchemotherapy-retroperitoneal lymph node dissection: Part I - vena cava. World J.
Urol. 1994. 12:182-186.
66.
Donohue, J.P., Thornhill, J.A., Foster, R.S. and Bihrle, R.: Vascular considerations in
postchemotherapy-retroperitoneal lymph node dissection: Part II. World J. Urol.
1994. 12:187-189.
67.
Baniel, J., Foster, R.S., Rowland, R.G., Bihrle, R. and Donohue, J.P.: Complications
of primary retroperitoneal lymph node dissection for low stage testicular cancer.
World J. Urol. 1994. 12(3):139-42.
68.
Foster, R.S., McNulty, A., Rubin, L.R., Bennett, R., Rowland, R.G., Sledge, G.W.,
Bihrle, R. and Donohue, J.P.: Fertility considerations in nerve-sparing retroperitoneal
lymph node dissection. World J. Urol. 1994. 12:136.
69.
Foster, R.S., Bihrle, R., Little, J.S., Rowland, R.G. and Donohue, J.P.: Stage II
nonseminomatous germ-cell testicular tumors: the Indiana experience and risk-benefit
analysis. World J. Urol. 1994. 12:143.
70.
Foster, R.S., Bihrle, R., Sanghvi, N. and Donohue, J.P.: High intensity focused
ultrasound for the treatment of benign prostatic hypertrophy. Semin Urol. 1994.
Aug;12(3):200-204.
71.
Bihrle, R., Adams, M. C., and Foster, R. S.: Adaptations of the Mitrofanoff principle
in adult continent urinary reservoirs. Techniques in Urology.Ed. David Albala and
Leonard Gomella. Lippincott-Raven Publishers. Philadelphia, pp94-100, 1995.
72.
Donohue, J.P., Thornhill, J.A., Foster, R.S., Bihrle, R., Rowland, R.G. and Einhorn,
L.H.: The role of retroperitoneal lymphadenectomy in clinical stage B testis Cancer:
the Indiana experience (1965 to 1989). J Urol. 1995. Jan;153(1):85-89.
73.
Baniel, J., Foster, R.S., Rowland, R.G., Bihrle, R. and Donohue, J. P.: Complications
of post chemotherapy retroperitoneal lymph node dissection. J Urol. 1995.
Mar;153:976-980.
2/16/16
Page 9
Richard Bihrle, M.D.
CV
74.
Fry, F.J., Sanghvi, N.T., Foster, R.S., Bihrle, R. and Hennige, C.: Ultrasound and
microbubbles: their generation, detection and potential utilization in tissue and organ
therapy-experimental. Ultrasound in Med. & Bio. 1995. 21(9):1227-1237.
75.
Albers, P., Foster, R.S., Bihrle, R., Adams, M.C. and Keating, M.A.: Ectopic ureters
and ureteroceles in adults. Urology. 1995. May;Vol. 45, No. 5:870-874.
76.
Leibovitch, I., Foster, R.S., Wass, J.L., Rowland, R.G., Bihrle, R., Little, J.S. Jr.,
Kopecky, K.K., Donohue, J.P. Color Doppler flow imaging for deep venous
thrombosis screening in patients undergoing pelvic lymphadenectomy and radical
retropubic prostatectomy for prostatic carcinoma. J Urol. 1995 Jun;153(6):1866-9.
77.
Little, J.S., Bihrle, R. and Foster, R.S.: Early urethral catheter removal following
radical prostatectomy: a pilot study. Urology. 1995. Sep;46(3):429-431.
78.
Baniel, J., Leibovitch, I., Foster, R.S., Rowland, R.G., Bihrle, R., Donohue, J.P.
Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for
testis cancer. J Urol. 1995 Oct;154(4):1373-5.
79.
Donohue, J.P., Thornhill, J.A., Foster, R.S., Bihrle, R., et al: Clinical stage B
nonseminomatous germ cell testis cancer: the Indiana University experience (19651989) using routine primary retroperitoneal lymph node dissection. Eur. J. of
Cancer. 1995. Oct;Vol.31A, No.10:1599-1604.
80.
Leibovitch, I., Rowland, R.G., Little, J.S., Foster, R.S. and Bihrle, R.: Cystography
after radical retropubic prostatectomy: clinical implications of abnormal findings.
Urology. 46:78-80, 1995.
81.
Leibovitch, I., Kaefer, M. and Bihrle, R.: An alternative surgical technique for the
management of afferent limb stricture in Kock pouch continent urinary diversion.
Urology. 1995. Dec;46(6):867-869.
82.
Little, J.S., Bihrle, R. and Foster, R.S.: Early urethral catheter removal following
radical prostatectomy: a pilot study. Urology. 1995, Sep;46(3):429-431.
83.
Bihrle, R., Adams, M.C., and Foster, R.S.: Adaptations of the Mitrofanoff principle
in adult continent urinary reservoirs. Tech Urol. 1995 Summer;1(2):94-101.
84.
Leibovitch, I., Little, J.S., Foster, R.S., Rowland, R.G., Bihrle, R. and Donohue, J.P.:
Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell
tumors. J Urol. 1996. 155:952-954.
85.
Foster, R.S., Baniel, J., Leibovitch, I., Curran, M., Bihrle, R., et al: Teratoma in the
orchiectomy specimen and volume of metastasis are predictors of retroperitoneal
teratoma in low stage nonseminomatous testis cancer. J Urol. 1996. 155:1943-1945.
2/16/16
Page 10
Richard Bihrle, M.D.
CV
86.
Nash, P.A., Schrepferman, C.G., Rowland, R.G., Young, J., Foster, R.S., Bihrle, R.
and Donohue, J.P.: The impact of pre-donated autologous blood and intra-operative
isovolaemic haemodilution on the outcome of transfusion in patients undergoing
radical retropubic prostatectomy. Brit J Urol. 1996. Jan;77:856-860.
87.
Hejase, M.J., Simonin, J.E., Bihrle, R., and Coogan, C.L.: Genital Fournier's
gangrene: experience with 38 patients. Urology. 1996. 47 (5).
88.
Hejase, M.J., Bihrle, R., Castillo, G., Coogan, C.L.: Amebiasis of the penis.
Urology. 1996. 48 (1).
89.
Nash, P.A., Bihrle, R., Gleason, P.E., Adams, M.C. and Hanke, C.W.: Moh’s
micrographic surgery and distal urethrectomy with immediate urethral reconstruction
for glanular carcinoma in situ with significant urethral extension. Urology. 1996.
47:108-110.
90.
Kincaide, L.F., Sanghvi, N.T., Cummings, O., Bihrle, R., Foster, R.S., Zaitsev, A.,
Phillips, M., Syrus, J. and Hennige, C.: Noninvasive ultrasonic subtotal ablation of
the prostate in dogs. AJVR. 1996, Aug;Vol.57, No.8:1225-1227.
91.
Coogan, C.L., Hejase, M.J., Wahle, G.R., Foster, R.S., Rowland, R.G. Bihrle, R.,
Donohue, J.P. Nerve sparing post-chemotherapy retroperitoneal lymph node
dissection for advanced testicular cancer. J Urol. 1996 Nov;156(5):1656-8.
92.
Coogan, C.L., Little, J.S., Bihrle, R., Foster, R.S. Urethral catheter removal prior to
hospital discharge following radical prostatectomy. Urology. 1997. Mar;49(3):400-3.
93.
Izes, J.K., Bihrle, W. and Bihrle, R.: Ileocecal valve resistance augmentation using
glutaraldehyde cross-linked collagen: a canine model for endoscopic salvage of the
leaking Indiana reservoir. J Urol. 1997. Oct;Vol. 158:1369-1371.
94.
Bihrle, R. The Indiana pouch continent urinary reservoir. Urol Clin North Am.
1997. Nov;24(4):773-9.
95.
Coogan, C.L., Foster, R.S., Rowland, R.G., Bihrle, R., Smith, E.R. Jr., Einhorn, L.H.,
Roth, B.J., Donohue, J.P. Postchemotherapy retroperitoneal lymph node dissection is
effective therapy in selected patients with elevated tumor markers after primary
chemotherapy alone. Urology. 1997. Dec;50(6):957-62.
96.
Hamidi, Asl K, Liepnieks, J.J., Bihrle, R., Benson, M.D. Local synthesis of amyloid
fibril precursor in AL amyloidosis of the urinary tract. Amyloid. 1998. Mar;5(1):4954.
97.
Nash, P.A., Leibovitch, I., Foster, R.S., Bihrle, R., Rowland, R.G., Donohue, J.P. En
bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph
node dissection for nonseminomatous testis cancer: indications, implications and
outcomes. J Urol. 1998 Mar;159(3):707-10.
2/16/16
Page 11
Richard Bihrle, M.D.
CV
98.
Tognoni, P.G., Foster, R.S., McGraw, P., Heilman, D., Bihrle, R., Rowland, R.G.,
Wahle, G.R., Einhorn, L.H., Donohue, J.P. Combined post-chemotherapy
retroperitoneal lymph node dissection and resection of chest tumor under the same
anesthetic is appropriate based on morbidity and tumor pathology. J Urol. 1998.
Jun;159(6):1833-5.
99.
Bell, B.B., Tognoni, P.G. and Bihrle, R.: Limbic encephalitis as a paraneoplastic
manifestation of renal cell carcinoma. J Urol. 1998. Sep;Vol. 160:828.
100.
Hermans, B.P., Foster, R.S., Bihrle, R., Little, S., Sandler, A., and Einhorn, L.H.: Is
retroperitoneal lymph node dissection necessary for adult paratesticular
rhabdomyoscaroma? J Urol. 1998. Dec;160(6 pt 1):2074-7.
101.
Wu, T., Bihrle, R. and Yum, M.N. Heterotopic adrenal cortical adenoma
masquerading as metastatic renal cell carcinoma. J Urol. 1999. Feb;161(2):595-6.
102.
Sweeney, C.J., Williams, S.D., Finch, D.E., Bihrle, R., Foster, R.S., Collins, M., Fox,
S., and Roth, B.J.: A phase II study of paclitaxel and Ifosfamide for patients with
advanced refractory carcinoma of the urothelium. Cancer. 1999. Aug;Vol. 86/No.
3:514-518.
103.
Sanghvi, N.T., Foster, R.S., Bihrle, R., Casey, R., Uchida, T. Phillips, M.H., Syrus,
J., Zaitsev, A.V., Marich, K.W. and Fry, F.J.: Noninvasive surgery of prostate tissue
by high intensity focused ultrasound: an updated report. Eur. J. of Urol. 1999.
Mar;9(1):19-29.
104.
DeMarco, R.T., Bihrle, R., and Foster, R.S.: Early catheter removal following
radical retropubic prostatectomy. Semin Urol Oncol. 2000. Feb;18(1):57-9.
105.
Bryan, D.E., Bell, B. and Bihrle, R.: Vesicointestinal fistula after combined ileal and
gastric bladder augmentation. J Urol. 2000. Oct;164(4):1302..
106.
Foster, R.S., Hermans, B., Bihrle, R. and Donohue, J.P.: Clinical stage I pure yolk
sac tumor of the testis in adults has different clinical behavior than juvenile yolk sac
tumor. J Urol. 2000. Dec;164(6):1943-4.
107.
Beck, S.D., Foster, R.S., Bihrle, R., Koch, M.O., Wahle, G.R. and Donohue, J.P.:
Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.
J Urol. 2001. May;165(5):11517-20.
108.
Foster, R.S., Bihrle, R. and Donohue, J.P. The benefits of nerve-sparing RPLND in
testicular cancer. Contemporary Urol. 2001. Aug;13(8):64-67.
109.
Soergel, T.M., Koch, M.O., Foster, R.S., Bihrle, R., Wahle, G., Gardner, T., and
Jung, S. Accuracy of predicting long-term prostate specific antigen outcome based on
2/16/16
Page 12
Richard Bihrle, M.D.
CV
early prostate specific antigen recurrence results after radical prostatectomy. J
Urol.166(6):2198-2201, December 2001.
110.
Davis, W.B., Treretola, S.O., Johnson, M.S., Patel, N.H., Namyslowski, J., Stecker,
M.S., McLennan, G., Shah, H., Bihrle, R. and Foster, R.S.: Percutaneous imagingguided access for the treatment of calculi in continent urinary reservoirs. Cardiovasc
and Intervene Radio. 2002. Jan;25:119-122.
111.
Sloan, J.C., Beck, S.D., Bihrle, R. and Foster, R.S. Bilateral testicular epidermoid
cysts managed by partial orchiectomy. J Urol. 2002. Jan;167(1):255-6.
112.
Foster, R. and Bihrle, R.: Current status of retroperitoneal lymph node dissection and
testicular cancer, when to operate. Cancer Control. Aug;9(4):288-83.
113.
Beck, S.D., Foster, R.S. Bihrle, R., Ulbright, T., Koch, M.O., Wahle, G.R., Einhorn,
L.H. and Donohue, J.P. Teratoma in the orchiectomy specimen and volume of
metastasis are predictors of retroperitoneal teratoma in post-chemotherapy
nonseminomatous testis cancer. J Urol. 2002. Oct;168(4 pt 1):1402-4.
114.
Hong, H., Koch, M.O., Foster, R.S., Bihrle, R., Gardner, T.A., Fyffe, J., Ulbright,
R.M., Eble, J.N. and Cheng, L. Anatomic distribution of periprostatic adipose tissue:
a mapping study of radical prostatectomy specimens. Cancer. 2003 Apr
1;97(7):1639-43.
115.
Mosharafa, A.A., Foster, R.S., Leibovich, B.C., Bihrle, R., Johnson, C. and Donohue,
J.P.: Is postchemotherapy resection of seminomatous elements associated with higher
acute morbidity: J Urol. 2003 Jun;169(6):2126-8.
116.
Koch, M.O., Nayee, A.H., Sloan, J., Gardner, T., Wahle, G.R., Bihrle, R. and Foster,
R.S. Early catheter removal after radical retropubic prostatectomy: long term
followup. J Urol. 2003 Jun;169(6):2170-2.
117.
Brandli, D.W., Koch, M.O., Foster, R.S., Bihrle, R. and Gardner, T.A.: Biochemical
disease-free survival in patients with a high prostate-specific antigen level (20-100
ng/mL) and clinically localized prostate cancer after radical prostatectomy. BJU Int.
2003 Jul;92(1):19-22.
118.
Mosharafa, A.A., Foster, R.S., Bihrle, R., Koch, M.O., Ulbright, T.M., Einhorn, L.H.
and Donohue, J.P. Does retroperitoneal lymph node dissection have a curative role for
patients with sex cord-stromal testicular tumors: Cancer. 2003 Aug 15;98(4):753-7.
119.
Mosharafa, A.A., Koch, M.O., Shalhav, A., Gardner, T., Logan, T., Bihrle, R.
Nephrectomy for metastatic renal cell carcinoma: Indiana University experience.
Urology. 2003 Oct; 62(4)L636-40.
120.
Foster, R,S., Beck, S.D., Bihrle, R. Secondary surgery in germ cell tumors-when and
how extensively should it be performed? World J. Urol. 2004 Mar22(1):37-40.
2/16/16
Page 13
Richard Bihrle, M.D.
CV
121.
Mosharafa, A.A., Foster, R.S., Leibovich, B.C., Ulbright, T.M., Bihrle, R., Einhorn,
L.H., Donohue, J.P. Histology in mixed germ cell tumors. Is there a favorite paring?
J Urol. 2004 Apr;171(4):1471-3.
122.
Foster, R.S., Beck, S.D., Bihrle, R., Secondary surgery in germ cell tumors-when and
how extensively should it be performed? World J Urol. 2004 Apr,22(1):37-40.
123.
Mosharafa, A.A., Foster, R.S., Koch, M.O., Bihrle, R., Donohue, J.P. Complications
of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol.
171(5):1839-41. May 2004.
124.
Cheng, L., Koch, M.O., Juliar, B.E., Daggy, J.K., Foster, R.S., Bihrle, R. and
Gardner, T.A. The combined percentage of gleason patterns 4 and 5 is the best
predictor of Cancer progression after radical prostatectomy. J. Clin. Oncol. 23(13),
2911-7. May 2005.
125.
Beck, S.D., Foster, R.S., Bihrle, R., Cheng, L., Ulbright, T.M., Donohue, J.P. Impact
of the number of positive lymph nodes on disease-free survival in patients with
pathological stage B1 nonseminomnatous germ cell tumor. J Urol. 2005
Jul:174(1):143-5.
126.
Beck, S.D., Foster, R.S., Bihrle, R., Einhorn, L.H., Donohue, J.P. Outcome analysis
for patients with elevated serum tumor markers at postchemotherapy retroperitoneal
lymph node dissection. J Clin Oncol. 2005 Sep 1;23(25);6149-56.
127.
Beck, S.D., Foster, R.S., Bihrle, R., Cheng, L., Donohue, J.P. Does the histology of
nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection
in pathological stage B1 germ cell tumors: J Urol 2005 Oct;174(4 pt 1):1287-90;
discussion 1290.
128.
Armatys, S.A., Koch, M.O., Bihrle, R., Gardner, T.A., Cheng, L. Is it necessary to
separate clinical stage T1c from T2 prostate adenocarcinoma. BJU Int. 2005
Oct;96(6):777-80.
129.
Beck, S.D., Foster, R.S., Bihrle, R., Einhorn, L.H., Donohue, J.P. Pathologic
findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal
lymph node dissection in advanced germ cell cancer. Urol Oncol. 2005 NovDec;23(6):423-30.
130.
Beck SD, Foster RS, Bihrle R, Donohue JP, Einhorn LH. Is full bilateral
retroperitoneal lymph node dissection always necessary for postchemotherapy
residual tumor? Cancer 2007 Sep 15;110(6):1235-40
131.
Beck, S.D., Peterson, M.D., Bihrle, R., Donohue, J.P., Foster, R.S. Short-term
morbidity of primary retroperitoneal lymph node dissection in a contemporary group
of patients. J Urol. 2007 Aug;178(2):504-6; discussion 506. Epub 2007 Jun 11.
2/16/16
Page 14
Richard Bihrle, M.D.
CV
132.
Beck, S.D., Foster, R.S., Bihrle, R., Einhorn, L.H., Donohue, J.P. Post chemotherapy
RPLND in patients with elevated markers: current concepts and clinical outcome.
Urol Clin North Am. 2007 May;34(2):219-25; abstract ix-x. Review
133.
Beck, S.D., Foster, R.S., Bihrle, R., Donohue, J.P. Significance of primary tumor
size and preorchiectomy serum tumor marker level in predicting pathologic stage at
retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell
tumors. Urology. 2007 Mar;69(3):557-9.
134.
Beck, S.D., Cheng, L., Bihrle, R., Donohue, J.P., Foster, R.S. Does the presence of
extranodal extension in pathological stage B1 nonseminomatous germ cell tumor
necessitate adjuvant chemotherapy? J Urol. 2007 Mar;177(3):944-6.
135.
Beck, S.D., Foster, R.S., Bihrle, R., Einhorn, L.H., Donohue, J.P. Post chemotherapy
RPLND in patients with elevated markers: current concepts and clinical outcome.
Urol Clin North Am. 2007 May;34(2):219-25.
136.
Beck, S.D., Peterson, M.D., Bihrle, R., Donohue, J.P., Foster, R.S. Short-term
morbidity of primary retroperitoneal lymph node dissection in a contemporary group
of patients. J Urol. 2007 Aug;178(2):504-6.
137.
Beck, S.D., Foster, R.S., Bihrle, R., Donohue, J.P., Einhorn, L.H. Is full bilateral
retroperitoneal lymph node dissection always necessary for post-chemotherapy
residual tumor? Cancer. 2007 Sep 15;110(6):1235-40.
138.
Beck, S.D., Foster, R.S., Bihrle, R., Donohue, J.P., Einhorn, L.H. Is full bilateral
retroperitoneal lymph node dissection always necessary for post-chemotherapy
residual tumor? Urol Onco. 2008 Mar-Apr:26(2):218-9.
139.
Brown, J.A., Bihrle, R., Foster, R.S. Delayed orchiectomy at postchemotherapy
retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic
pattern consistent with testicular primary: assessment of pathologic findings.
Urology. 2008 May;71(5):911-4.
140.
Armatys, S.A., Mellon, M.J., Beck, S.D., Koch, M.O., Foster, R.S., Bihrle, R. Use of
ileum as ureteral replacement in urological reconstruction. J Urol. 2009
Jan;181(1):177-81.
141.
Beck, S.D., Foster, R.S., Bihrle, R., Einhorn, L.H., Donohue, J.P. Long-term
outcome for patients with high volume retroperitoneal teratoma undergoing postchemotherapy surgery. J Urol. 2009 Jun;181(6):2526-32.
142.
Peterson, M, Beck, S.D., Bihrle, R., Einhorn, L.H., Foster, R.S. Results of
retroperitoneal lymph node dissection after chemotherapy in patients with pure
seminoma in the orchiectomy specimen but elevated serum alpha-fetoprotein. BJU
Int. 2009 Jul;104(2):176-8.
2/16/16
Page 15
Richard Bihrle, M.D.
CV
143.
Regan, S.M., Beck, S.D., Bihrle, R., Foster, R.S. Role of routine stentograms
following urinary diversion in modern practice. Can J Urol. 2009 Jun;16(3):4660-3.
144.
Bahler, C.D., Foster, R.S., Bihrle, R., Beck, S.D., Gardner, T.A., Sundaram, C.P.,
Masterson, T.A., Cheng, L., Koch, M.O. Radical prostatectomy as initial
monotherapy for patients with pathologically confirmed high-grade prostate cancer.
BJU Int. 2010 May;105(10):1372-6.
145.
Ehrlich, Y., Foster, R.S., Bihrle, R., Cheng, L., Tong, Y ., Koch, M.O. Division of
Prostatic Anterior Fibromuscular Stroma Reduces Urethral Resistance in an Ex VivoHuman Prostate Model. Urology. 2010 Jun 3 (in press)
146.
Jacobsen, N.E., Beck, S.D., Jacobson, L.E., Bihrle, R., Einhorn, L.H., Foster, R.S. Is
Retroperitoneal Histology Predictive of Liver Histology at Concurrent PostChemotherapy Retroperitoneal Lymph Node Dissection and Hepatic Resection? J
Urol. 2010 Jul 17 (in press)
2/16/16
Page 16
Richard Bihrle, M.D.
CV
CHAPTERS:
Libertino, J.A., Bihrle, R., Cyr, J., and Watkins, E.: Extended surgery for renal cell carcinoma
with extension into the inferior vena cava. In: deKernion, J.: Renal Cell Cancer. International
Perspectives in Urology. 1985.
Libertino, J.A. and Bihrle, R.: Extended surgery for renal cell carcinoma with extension into the
inferior vena cava. In: Libertino, J.A. and Zinman, L.: Reconstructive Urologic Surgery;
Pediatric and Adult. Baltimore, Williams and Wilkins (Second Edition). 1987.
Rowland, R.G., Mitchell, M.E. and Bihrle, R.: The cecoileal continent urinary reservoir. In:
Libertino, J.A. Pediatric and Adult Reconstructive Urologic Surgery. Baltimore, MD: Williams
and Wilkins. 321-329, 1987.
Rowland, R.G., Mitchell, M.E. and Bihrle, R.: Alternative techniques for a continent urinary
reservoir. In: Donohue, J.P. The Urologic Clinics of North America. Philadelphia, PA: W.B.
Saunders Co., 797-804, 1987.
Bihrle, R., Donohue, J.P. and Foster, R.S.: Complications of retroperitoneal lymph node
dissection. Urologic Clinics of North America. Vol. 15:2. W.B. Saunders, Philadelphia. May
1988.
Donohue, J.P., Rowland, R.G., and Bihrle, R.: Transabdominal retroperitoneal lymph node
dissection. In: Skinner, D.G. and Lieskovsky, G. Diagnosis and Management of Genitourinary
Cancer. Philadelphia, PA: W.B. Saunders Co. 802-816, 1988.
Bihrle, M.D. and Donohue, J.P.: Complications in adrenal surgery. In: Smith, R.B. and Ehrlich,
R.M., eds. Complications of Urologic Surgery. Philadelphia: W.B. Saunders Co. 116-127,
1990.
Foster, R.S., Donohue, J.P. and Bihrle, R.: Retroperitoneal lymphadenectomy. Operative
Urology. Ed: F.F. Marshall, 100-108, W.B. Saunders, 1991.
Bihrle, R. and Foster, R.S.: Continent ileocecal reservoirs: the Indiana pouch. Bladder
Reconstruction and Continent Urinary Diversion. L.R. King, A.S. Story, G.D. Webster (Eds.).
308-315, Mosby Yearbook, 1991.
Donohue, J.P., Bihrle, R and Foster, R.S.: Evolving concepts in surgical management of testis
Cancer. Lepor, H. and Lawson, R.K. (eds.), Therapy for Genitourinary Cancer. 1992.
Donohue, J.P. and Bihrle, R.: The retroperitoneum in genitourinary surgery; adrenal surgery. In:
Surgical Management of Urologic Disease; An Anatomic Approach. Ed: Michael J. Droller.
Mosby Year Book, Inc., St. Louis, MO. 24:325-341, 1992.
Foster, R.S., Donohue, J.P., Bihrle, R. and Rowland, R.G.: Testicular tumor. In: Practice of
Urology. W.W. Norton & Co., Vol. 2, Chapter 7, 1992.
2/16/16
Page 17
Richard Bihrle, M.D.
CV
Foster, R.S., Bihrle, R., Sanghvi, N.T., Donohue, J.P. and Fry, F.J.: High intensity focused
ultrasound in the treatment of human benign prostatic hypertrophy. In: Benign Prostatic
Hyperplasia. K. Kurch and D. Newling (ed) Wiley-Liss, New York. Vol. 386, 1994.
Foster, R.S., Donohue, J.P., Bihrle, R. and Rowland, R.G.: Testicular tumor. In: Clinical
Urologic Practice. B.S. Stein (ed) W.W. Norton & Co., New York. 1027-1039, 1995.
Bihrle, R. and Foster, R. S.: Use of the ileocecal segment and right colon in continent diversion
and bladder replacement. In: Atlas of the Urologic Clinics of North America. Ed. John Libertino
and Peter Nieh. W.B. Saunders Publisher. Philadelphia. Vol. 3, No. 2:29-44, October 1995.
Bihrle, R., Foster, R.S. and Sanghvi, N.T.: High intensity focused ultrasound in the treatment of
prostatic disease. In: Topics in Clinical Urology: Techniques for Ablation of Benign and
Malignant Prostate Tissue. Ed. Joseph A. Smith and Douglas F. Milam. Igaku-Shoin Med
Publishers. New York. Chapter 12, 1996.
Donohue, J.P., Foster, R.S., Rowland, R.G. and Bihrle, R.: Cytoreductive surgery for
nonseminomatous germ cell Cancer. In: Principles and Practice of Genitourinary Oncology. Ed.
Derek Raghavan, Howard I. Scher, Steven A. Leibel and Paul H. Lange. Lippincott-Raven
Publishers. Philadelphia, 1997. Chapter 70.
Foster, R.S., Bihrle, R., and Donohue, J.P.: Surgery for germ cell tumors: current status in the
USA. In: Germ Cell Tumours. V.P. Harnden, J.K. Joffe and W.G. Jones (eds) Springer-Verleg
London, Ltd., Great Britain, 2002.
2/16/16
Page 18